ZA921111B - (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins. - Google Patents

(Carboxyl) alkyloxyalkyl derivatives of cyclodextrins.

Info

Publication number
ZA921111B
ZA921111B ZA921111A ZA921111A ZA921111B ZA 921111 B ZA921111 B ZA 921111B ZA 921111 A ZA921111 A ZA 921111A ZA 921111 A ZA921111 A ZA 921111A ZA 921111 B ZA921111 B ZA 921111B
Authority
ZA
South Africa
Prior art keywords
cyclodextrins
carboxyl
alkyloxyalkyl
derivatives
alkyloxyalkyl derivatives
Prior art date
Application number
ZA921111A
Other languages
English (en)
Inventor
Jozsef Szejtli
Laszlo Jicsinszky
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA921111B publication Critical patent/ZA921111B/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
ZA921111A 1991-02-15 1992-02-14 (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins. ZA921111B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200319 1991-02-15

Publications (1)

Publication Number Publication Date
ZA921111B true ZA921111B (en) 1993-08-16

Family

ID=8207519

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921111A ZA921111B (en) 1991-02-15 1992-02-14 (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins.

Country Status (13)

Country Link
EP (2) EP0571416A1 (hu)
JP (1) JPH06505039A (hu)
AU (1) AU657304B2 (hu)
CA (1) CA2104097A1 (hu)
FI (1) FI933588A0 (hu)
HU (1) HUT64979A (hu)
IE (1) IE920485A1 (hu)
IL (2) IL100856A (hu)
MX (1) MX9200643A (hu)
NO (1) NO932903L (hu)
NZ (1) NZ241449A (hu)
WO (1) WO1992014762A1 (hu)
ZA (1) ZA921111B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053399B1 (es) * 1993-01-11 1995-02-16 Univ Madrid Complutense Procedimiento para la obtencion de derivados de beta-ciclodextrina.
DE4428654A1 (de) 1994-08-12 1996-02-15 Consortium Elektrochem Ind Wasserlösliche Cyclodextrinderivate mit lipophilen Substituenten und Verfahren zu ihrer Herstellung
DE69733664T3 (de) 1996-04-19 2011-04-14 Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
JP6154163B2 (ja) * 2013-03-15 2017-06-28 独立行政法人国立高等専門学校機構 水不溶性シクロデキストリンポリマーおよびその製造方法
CN103554307B (zh) * 2013-09-25 2017-01-11 南京师范大学 羧甲基‑羟丙基‑β‑环糊精及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146841A3 (de) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Wasserlösliche Mischether des beta-Cyclodextrins und ein Verfahren zu ihrer Herstellung
NZ225045A (en) * 1987-07-01 1990-06-26 Janssen Pharmaceutica Nv Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent

Also Published As

Publication number Publication date
AU657304B2 (en) 1995-03-09
HU9302345D0 (en) 1993-10-28
WO1992014762A1 (en) 1992-09-03
NO932903D0 (no) 1993-08-16
AU1192092A (en) 1992-09-15
IL100856A0 (en) 1992-11-15
NO932903L (no) 1993-08-16
JPH06505039A (ja) 1994-06-09
FI933588A (fi) 1993-08-13
EP0571416A1 (en) 1993-12-01
IE920485A1 (en) 1992-08-26
NZ241449A (en) 1993-06-25
HUT64979A (en) 1994-03-28
EP0499322A1 (en) 1992-08-19
IL118838A0 (en) 1996-10-31
CA2104097A1 (en) 1992-08-16
FI933588A0 (fi) 1993-08-13
IL100856A (en) 1998-03-10
MX9200643A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU2280592A (en) New heterocyclic derivatives
ZA924746B (en) Substituted 1h-3-aryl-pyrrolidine-2,4-dione derivatives
EP0710672A3 (en) Derivatives of cyclodextrins
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
GR3023621T3 (en) 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives
AU2706292A (en) Heterobiaryl derivatives
HU9203994D0 (en) Imidazo-pyridine derivatives
AU1604492A (en) Indole derivatives
AU2856692A (en) Cephalosporin derivatives
HU9202768D0 (en) Cyano-phenyl-pyrrole derivatives
AU1632092A (en) Benzofuran derivatives
ZA929934B (en) Heterocyclic derivatives.
ZA928742B (en) Heterocyclic derivatives.
AU2630592A (en) Point level detector
AU2544092A (en) Carboxylic polysaccharide derivatives
ZA921111B (en) (Carboxyl) alkyloxyalkyl derivatives of cyclodextrins.
AU1033992A (en) 3-quinuclidine derivatives
OA09716A (en) Benzoxaiole derivatives.
EP0520435A3 (en) Dc-89 derivatives
ZA922976B (en) 4-Aryl-3-heteroarylureidoquinoline derivatives
AU8769291A (en) Deoxyhypusyl hydroxylase inhibitors
HU9201889D0 (en) New cephem derivatives
AU1732692A (en) Substituted imidazolinylpyrimidines
AU2686592A (en) Tetraphenylporphyn derivatives